Find in Library

Hybrid nanoparticles have emerged as promising tools in cancer diagnosis and treatment, offering the potential for early detection and precise eradication of malignant cells by integrating diverse materials. However, navigating the intricacies, limitations, and hurdles within this domain underscores the importance of thoughtful decision-making. This editorial provides a comprehensive exploration of the merits and challenges of nanotechnology in the context of cancer diagnosis, therapy, and theranostics. It sheds light on the current applications and delves into the promising future prospects in this field. By doing so, this editorial aims to foster a deeper understanding of the intricacies involved in designing efficient protocols for hybrid nanoparticle production, contributing to advancing cancer management strategies.